Prognosis
Instead of the dreaded Pap smear.
View in browser
Bloomberg

Prognosis is exclusively for Bloomberg.com subscribers. As a loyal reader, you’re receiving a complimentary trial. If you’d like to continue receiving Prognosis, and gain unlimited digital access to all of Bloomberg.com, we invite you to subscribe now at the special rate of $149 for your first year (usually $299).

Hi, it’s Amber in Hong Kong, where less than half of eligible women get their recommended cervical cancer screening. If only the procedure was less unpleasant … 

Today’s must-reads

  • Merck will spend $10 billion for Verona Pharma as Keytruda’s patent expiration looms.
  • US measles cases in 2025 are now the highest in more than three decades.
  • Stopping antidepressants doesn’t lead to as many withdrawal symptoms as previously thought. 

Testing pad

As someone who has reported on cancer research for some years, I’ve long known that cervical cancer is one of the most preventable cancers, thanks to vaccination and early screening. Yet, I must confess I’ve never received a screening for HPV, the human papillomavirus that’s the primary cause of cervical cancer. The thought of a Pap smear makes me squirm. 

To get the traditional cervical test, a women lies on her back with her feet in stirrups. The gynecologist uses a speculum to see the cervix, which is then scraped or swabbed to collect tissue. 

I spoke with Pui-Wah Choi, founder of WomenX Biotech, at Women’s Health in Focus, the first summit of its kind in Hong Kong. She said conversations with friends and family who were hesitant to undergo the procedure inspired her to create a non-invasive test for HPV. This invention, PadX, takes the form of a familiar household item: a menstrual pad.

Choi, who studied biomarkers doing research at Harvard Medical School and Brigham and Women’s Hospital in Boston, knew the key was to find the right liquid. Menstrual blood fits the bill: It passes through the cervix every month, bringing with it both cervical cells and HPV.

PadX looks like a disposable sanitary pad with a testing strip sewn into it. Women wear the pad for a few hours while their period flow is the heaviest, then mail it to a lab in the sealed bag provided in the kit. 

In a local study, the test showed accuracy on par with a Pap smear, Choi told me. Since launching earlier this year, Choi said WomenX has sold more than 1,000 kits through pharmacies and partnerships with corporations and nonprofit organizations in Hong Kong.

Women’s health advocates have cheered advancements that make HPV tests less invasive. Last year, Becton, Dickinson and Company and Roche Molecular Systems both launched HPV tests that women can self-administer at doctors’ offices. Another Hong Kong startup sells a urine test designed for at-home sample collection.

WomenX is now working to apply for product registration in mainland China, with its sights on Southeast Asia and Africa, where cervical cancer remains a major cause of death for women. The privacy that PadX offers can alleviate religious concerns that some women in those regions may have about exposing their bodies to medical workers, Choi said.

“HPV is a massive global problem, hugely stigmatized as a sexually transmissible disease,” said Maaike Steinebach, the organizer of Women’s Health in Focus. But, she added, “solutions are coming – from vaccine to testing to treatment.” 

Beyond HPV, Choi sees menstrual blood as a treasure trove that could be used to test for everything from endometriosis to menopause hormones. That puts WomenX on the same path as a small group of firms globally aiming to corral resources and drive innovation for women’s health, an already-under-invested area that faces the threat of funding cuts in the US.

“Ultimately, we want to make medicine more accessible, to bring more people back into the medical system,” Choi said. — Amber Tong

What we’re reading

The US Justice Department is investigating UnitedHealth’s Medicare billing practices, the Wall Street Journal reported

The European heat wave has caused an estimated 2,300 deaths, Reuters reports

If you hate exercising, matching workouts to your personality type could help, the Washington Post reports

Contact Prognosis

Health questions? Have a tip that we should investigate? Contact us at AskPrognosis@bloomberg.net.

Follow Us

Like getting this newsletter? There's more where that came from. Browse all our weekly and daily emails to get even more insights from your Bloomberg.com subscription.

Want to sponsor this newsletter? Get in touch here.

You received this message because you are subscribed to Bloomberg's Prognosis newsletter. If a friend forwarded you this message, sign up here to get it in your inbox.
Unsubscribe
Bloomberg.com
Contact Us
Bloomberg L.P.
731 Lexington Avenue,
New York, NY 10022
Ads Powered By Liveintent Ad Choices